Skip to content

Clinical trials

Completed Phase 2 Urinary Bladder Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Phase: Phase 2 Status: Completed Clear all

168 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
20016
20023
200311
20046
20055
20068
20079
200813
20097
20104
20114
20124
20133
20149
20157
20165
20177
201812
20194
20207
20216
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed168

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)15
Memorial Sloan Kettering Cancer Center11
M.D. Anderson Cancer Center6
SWOG Cancer Research Network6
Eastern Cooperative Oncology Group5
Eli Lilly and Company4
Dana-Farber Cancer Institute3
European Organisation for Research and Treatment of Cancer - EORTC3
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano3
Hoffmann-La Roche3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms168
Carcinoma, Transitional Cell32
Urethral Neoplasms31
Ureteral Neoplasms14
Non-Muscle Invasive Bladder Neoplasms9
Kidney Neoplasms8
Lung Neoplasms8
Neoplasm Metastasis8
Urologic Neoplasms7
Carcinoma, Non-Small-Cell Lung6

Trials

Showing 1 to 25 of 168. Each trial links to its page on Pharma Observatory.

68 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.